Ticagrelor Impurity N
|
|
Ticagrelor Impurity N Eigenschaften
- Siedepunkt:
- 782.0±70.0 °C(Predicted)
- Dichte
- 1.63±0.1 g/cm3(Predicted)
- pka
- 13.26±0.70(Predicted)
Sicherheit
Ticagrelor Impurity N Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol is an impurity of Ticagrelor (T437700) which is an anticoagulant used in the treatment of acute coronary syndromes.Ticagrelor Impurity N Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Ticagrelor Impurity N Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 64)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
ANHUI WITOP BIOTECH CO., LTD | +8615255079626 |
eric@witopchemical.com | China | 23541 | 58 |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11922 | 58 |
Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +8617865335152 |
Mandy@hangyubiotech.com | China | 10986 | 58 |
Moxin Chemicals | +8617320513646 |
mike@molcoo.com | China | 9558 | 58 |
S.Z. PhyStandard Bio-Tech. Co., Ltd. | 0755-4000505016 13380397412 |
3001272453@qq.com | China | 5047 | 50 |
Beijing Comparison Pharmaceutical Technology Co., Ltd | 010-010-52878169 15801002657 |
sales@bjcomparison.com | China | 4717 | 58 |
ChemStrong Scientific Co.,Ltd | 0755-0755-66853366 13670046396 |
sales@chem-strong.com | China | 18070 | 56 |
Wuxi Zhongkun Biochemical Technology Co., Ltd. | 0510-85629785 18013409632 |
sales@reading-chemicals.com | China | 15178 | 58 |
Shanghai Kewel Chemical Co., Ltd. | 021-64609169 18901607656 |
greensnown@163.com | China | 9906 | 50 |
Pharmacodia (Beijing) Co.,Ltd | +86-400-851-9921 |
sales@pharmacodia.com | China | 2317 | 55 |
1643378-47-5()Verwandte Suche:
- Ticagrelor diastereoisomer 1
- Ticagrelor diastereoisomer 2
- (1R,2R,3S,5R)-3-(7-(((1R,2R)-2-(3,4- difluorophenyl)cyclopropyl)amino)-5- (propylthio)-3H-[1,2,3]triazolo[4,5- d]pyrimidin-3-yl)-5-(2- hydroxyethoxy)cyclopentane-1,2-diol compound with (1R,2R,3S,5R)-3-(7- (((1S,2S)-2-(3,4- difluorophenyl)cyclopropyl)amino
- ent-Ticagrelor
- (1R,2R,3S,5R)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl) amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5- (2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1R,2R,3S,5R)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl) amino)-5
- 2-(((3aR,4S,6R,6aS)-6-((6-chloro-5-((3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4
- (1R,2R,3S,5R)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1R,2R,3S,5R)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)c
- Ticagrelor impurity 3/Ticagrelor 4-Fluoro Impurity/(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(4-Fluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol
- Ticagrelor Imp.N
- Ticagrelor TK-IMP10
- Ticagrelor 3-Desfluoro
- 1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-
- 4-Fluoro Ticagrelor
- (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol? (Ticagrelor Impurity)
- (1R,2R,3S,5R)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl) amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5- (2-hydroxyethoxy)cyc
- Ticagrelor Acetyl Impurity / Ticagrelor EP Impurity-N
- 1643378-47-5
- C23H29FN6O4S
- DCP